Establishing novel EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma.

○Kou Yonemaru

4:06 PM - 4:18 PM

[30-503-pm04S] Establishing novel EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma.

○Kou Yonemaru¹, Ayumi Kanemaru^1,2, Satoru Shinriki³, Hideyuki Saito^1,4, Hirofumi Jono^1,4 (1. Department of Clinical Pharmaceutical Sciences, Kumamoto University, 2. Clinical Research, Innovation and Education Center, Tohoku University, 3. Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, 4. Department of Pharmacy, Kumamoto University Hospital)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30-503-pm] Pharmacotherapies (Cancer) 1

[30-503-pm04S] Establishing novel EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma.

Password